Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aevi Genomic Medicine, Llc (MDGN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aevi Genomic Medicine, Llc. Table 2 shows the detailed insider transactions. This company's CIK number is 1138776.
Total stock buying since 2014: $14,984,114.
Total stock sales since 2014: $1,916,188.
Total stock option exercises since 2014: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2020 | 100,000 | $250,000 | 0 | $0 | 0 | $0 |
2019 | 17,045,652 | $549,232 | 4,098,752 | $549,232 | 0 | $0 |
2018 | 5,170,040 | $4,976,906 | 0 | $0 | 0 | $0 |
2017 | 2,166,788 | $3,331,968 | 0 | $0 | 0 | $0 |
2016 | 3,000 | $15,798 | 0 | $0 | 0 | $0 |
2015 | 423,074 | $2,987,980 | 144,825 | $1,366,956 | 0 | $0 |
2014 | 633,122 | $2,872,230 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2020-06 | 100,000 | $250,000 | 0 | $0 | 0 | $0 |
2019-12 | 17,045,652 | $549,232 | 4,098,752 | $549,232 | 0 | $0 |
2018-11 | 68,000 | $78,948 | 0 | $0 | 0 | $0 |
2018-08 | 5,102,040 | $4,897,958 | 0 | $0 | 0 | $0 |
2017-10 | 793,651 | $999,997 | 0 | $0 | 0 | $0 |
2017-09 | 83,775 | $100,530 | 0 | $0 | 0 | $0 |
2017-08 | 30,831 | $36,792 | 0 | $0 | 0 | $0 |
2017-04 | 200,000 | $311,000 | 0 | $0 | 0 | $0 |
2017-03 | 1,058,531 | $1,883,649 | 0 | $0 | 0 | $0 |
2016-12 | 3,000 | $15,798 | 0 | $0 | 0 | $0 |
2015-10 | 223,074 | $1,449,981 | 0 | $0 | 0 | $0 |
2015-09 | 0 | $0 | 94,825 | $944,457 | 0 | $0 |
2015-03 | 50,000 | $422,499 | 50,000 | $422,499 | 0 | $0 |
2015-02 | 150,000 | $1,115,500 | 0 | $0 | 0 | $0 |
2014-12 | 545,122 | $2,234,994 | 0 | $0 | 0 | $0 |
2014-06 | 28,000 | $222,936 | 0 | $0 | 0 | $0 |
2014-05 | 60,000 | $414,300 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-06-09 | Cola Michael F (Chief Executive Officer) | Buy | 100,000 | 2.50 | 250,000 |
2019-12-19 | Medimmune Ltd (10% Owner) | Buy | 12,946,900 | .00 | 0 |
2019-12-05 | Neil Garry Arthur (Chief Scientific Officer) | Buy | 2,049,376 | .13 | 274,616 |
2019-12-05 | Barer Sol J (Director) | Sale | 4,098,752 | .13 | 549,232 |
2019-12-05 | Cola Michael F (President and CEO) | Buy | 2,049,376 | .13 | 274,616 |
2018-11-07 | Grano Joseph J Jr (Director) | Buy | 68,000 | 1.16 | 78,948 |
2018-08-15 | Children's Hospital Of Philadelphia Foundation | Buy | 2,551,020 | .96 | 2,448,979 |
2018-08-15 | Barer Sol J (Director) | Buy | 2,551,020 | .96 | 2,448,979 |
2017-10-17 | Neil Garry Arthur (Chief Scientific Officer) | Buy | 75,000 | 1.26 | 94,500 |
2017-10-17 | Duncan Barbara Gayle | Buy | 59,524 | 1.26 | 75,000 |
2017-10-17 | Grano Joseph J Jr | Buy | 39,683 | 1.26 | 50,000 |
2017-10-17 | Clemow Alastair J | Buy | 19,841 | 1.26 | 24,999 |
2017-10-17 | Barer Sol J | Buy | 421,032 | 1.26 | 530,500 |
2017-10-17 | Bauer Eugene A | Buy | 19,841 | 1.26 | 24,999 |
2017-10-17 | Gantz Wilbur H | Buy | 39,683 | 1.26 | 50,000 |
2017-10-17 | Cola Michael F (President and CEO) | Buy | 119,047 | 1.26 | 149,999 |
2017-09-01 | Harper Philip R (10% Owner) | Buy | 83,775 | 1.20 | 100,530 |
2017-08-23 | Harper Philip R (10% Owner) | Buy | 5,700 | 1.20 | 6,840 |
2017-08-22 | Harper Philip R (10% Owner) | Buy | 4,661 | 1.20 | 5,593 |
2017-08-10 | Harper Philip R (10% Owner) | Buy | 20,470 | 1.19 | 24,359 |
2017-04-28 | Barer Sol J (Director) | Buy | 100,000 | 1.57 | 156,700 |
2017-04-26 | Barer Sol J (Director) | Buy | 100,000 | 1.54 | 154,300 |
2017-03-24 | Harper Philip R (10% Owner) | Buy | 53,826 | 1.60 | 86,121 |
2017-03-23 | Harper Philip R (10% Owner) | Buy | 4,705 | 1.60 | 7,528 |
2017-03-22 | Harper Philip R (10% Owner) | Buy | 1,000,000 | 1.79 | 1,790,000 |
2016-12-08 | Grano Joseph J Jr (Director) | Buy | 3,000 | 5.27 | 15,798 |
2015-10-06 | Neil Garry Arthur (Chief Scientific Officer) | Buy | 15,384 | 6.50 | 99,996 |
2015-10-06 | Grano Joseph J Jr | Buy | 15,384 | 6.50 | 99,996 |
2015-10-06 | Barer Sol J | Buy | 153,846 | 6.50 | 999,999 |
2015-10-06 | Cola Michael F (President and CEO) | Buy | 38,460 | 6.50 | 249,990 |
2015-09-21 | Blech Isaac (Director) | Sale | 94,825 | 9.96 | 944,457 |
2015-03-20 | Barer Sol J | Buy | 50,000 | 8.45 | 422,499 |
2015-03-20 | Bauer Eugene A | Sale | 50,000 | 8.45 | 422,499 |
2015-02-20 | Barer Sol J | Buy | 50,000 | 7.55 | 377,500 |
2015-02-19 | Barer Sol J | Buy | 100,000 | 7.38 | 738,000 |
2014-12-01 | Applebaum Scott (Chief Legal Officer) | Buy | 6,098 | 4.10 | 25,001 |
2014-12-01 | Neil Garry Arthur (Global Head of R&D) | Buy | 24,390 | 4.10 | 99,998 |
2014-12-01 | Grano Joseph J Jr | Buy | 48,780 | 4.10 | 199,997 |
2014-12-01 | Mcmurray Stephen D | Buy | 2,439 | 4.10 | 9,999 |
2014-12-01 | Clemow Alastair J T | Buy | 12,195 | 4.10 | 49,999 |
2014-12-01 | Barer Sol J | Buy | 365,854 | 4.10 | 1,500,001 |
2014-12-01 | Gantz Wilbur H | Buy | 24,390 | 4.10 | 99,998 |
2014-12-01 | Cola Michael F (President and CEO) | Buy | 60,976 | 4.10 | 250,001 |
2014-06-13 | Barer Sol J | Buy | 28,000 | 7.96 | 222,936 |
2014-05-12 | Barer Sol J | Buy | 60,000 | 6.91 | 414,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of MDGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aevi Genomic Medicine, Llc (symbol MDGN, CIK number 1138776) see the Securities and Exchange Commission (SEC) website.